PDCD1 and neoplasm: Indeed, the infusion ex vivo 70-kDa heat shock protein (Hsp70)/IL-2-activated NK cells together with the anti-PD-1 antibody was shown to be highly effective in local tumor control as well as improving the infiltration of CD8+ cytotoxic lymphocytes and NK1.1+ cells in the tumor bed [175].